A One-Two Punch Against Cystic Fibrosis, And Maybe Someday Other Diseases Too – Forbes
 Xconomy |
A One-Two Punch Against Cystic Fibrosis, And Maybe Someday Other Diseases Too
Forbes New data on experimental drug combination being developed by Vertex Pharmaceuticals of Cambridge, Mass., should give hope to tens of thousands of people suffering from cystic fibrosis, the deadly lung disease that afflicts 70000 people worldwide and … Vertex Cystic Fibrosis Combo Aids Breathing in Patients Vertex Reports Interim Analysis Data From Phase 2 Study Of VX-809 And Kalydeco Vertex: Two-Drug Cystic Fibrosis Therapy Improves Lung Function |
Related posts:
- Novartis Lung Drug QVA149 Meets Goals In Late-Stage Trial – Wall Street Journal
- GlaxoSmithKline: HIV-1 drug study meets key goal – MarketWatch
- Novartis lung drug meets goals in late-stage trials – Reuters
- WHO on bird flu research: Publish in full… someday – Los Angeles Times
- Range of brain diseases could be treated by single drug – BBC News
You must be logged in to post a comment Login